Together, phosphorylation of tau protein mediates the pathological process of Alzheimer’s disease (AD) or PD, which is a potential therapeutic target treatment for neurodegenerative disease (Winer et al., 2018; Chen et al., 2019). The gene discussed is MAPT; the disease is Alzheimer disease.